PT1207898E - Tratamento da conjuntivite com proteinas histacalinicas - Google Patents

Tratamento da conjuntivite com proteinas histacalinicas

Info

Publication number
PT1207898E
PT1207898E PT00954784T PT00954784T PT1207898E PT 1207898 E PT1207898 E PT 1207898E PT 00954784 T PT00954784 T PT 00954784T PT 00954784 T PT00954784 T PT 00954784T PT 1207898 E PT1207898 E PT 1207898E
Authority
PT
Portugal
Prior art keywords
proteins
treatment
histacalinic
conjunctivity
effective
Prior art date
Application number
PT00954784T
Other languages
English (en)
Inventor
Nuttall Patricia Anne
Paesen Guido Christiaan
Original Assignee
Evolutec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evolutec Ltd filed Critical Evolutec Ltd
Publication of PT1207898E publication Critical patent/PT1207898E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/858—Proteins from animals other than mammals or birds insects; venom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Surface Treatment Of Glass (AREA)
  • Polarising Elements (AREA)
PT00954784T 1999-09-01 2000-08-24 Tratamento da conjuntivite com proteinas histacalinicas PT1207898E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9920674.0A GB9920674D0 (en) 1999-09-01 1999-09-01 Treatment of conjunctivitis

Publications (1)

Publication Number Publication Date
PT1207898E true PT1207898E (pt) 2005-05-31

Family

ID=10860170

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00954784T PT1207898E (pt) 1999-09-01 2000-08-24 Tratamento da conjuntivite com proteinas histacalinicas

Country Status (17)

Country Link
US (1) US6737399B2 (pt)
EP (1) EP1207898B1 (pt)
JP (1) JP2003508445A (pt)
CN (1) CN1382057A (pt)
AT (1) ATE289203T1 (pt)
AU (1) AU780773B2 (pt)
BR (1) BR0013665A (pt)
CA (1) CA2382473A1 (pt)
DE (1) DE60018192T2 (pt)
DK (1) DK1207898T3 (pt)
ES (1) ES2235930T3 (pt)
GB (1) GB9920674D0 (pt)
HK (1) HK1046362B (pt)
MX (1) MXPA02001807A (pt)
NZ (1) NZ517218A (pt)
PT (1) PT1207898E (pt)
WO (1) WO2001015719A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307544D0 (en) * 2003-04-01 2003-05-07 Evolutec Ltd Treatment method
GB0809279D0 (en) * 2008-05-21 2008-06-25 Varleigh Ltd Histamine binding protein
WO2017053923A1 (en) * 2015-09-25 2017-03-30 Okogen, Llc Viral conjunctivitis treatment using ranpirnase and/or amphinase
GB201720505D0 (en) * 2017-12-08 2018-01-24 Volution Immuno Pharmaceuticals Sa Methods for treatment of neuropathic pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2236807T3 (es) * 1996-05-18 2005-07-16 Evolutec Limited Moleculas de union de aminas vasoactivas.
CA2309809A1 (en) * 1997-11-26 1999-06-03 Oxford Vacs Ltd. Histamine and serotonin binding molecules

Also Published As

Publication number Publication date
WO2001015719A2 (en) 2001-03-08
ES2235930T3 (es) 2005-07-16
JP2003508445A (ja) 2003-03-04
DE60018192T2 (de) 2005-12-29
HK1046362B (zh) 2005-09-02
GB9920674D0 (en) 1999-11-03
DE60018192D1 (de) 2005-03-24
WO2001015719A3 (en) 2001-05-10
AU6713900A (en) 2001-03-26
US20020151499A1 (en) 2002-10-17
CA2382473A1 (en) 2001-03-08
HK1046362A1 (en) 2003-01-10
NZ517218A (en) 2004-10-29
EP1207898B1 (en) 2005-02-16
US6737399B2 (en) 2004-05-18
DK1207898T3 (da) 2005-06-13
MXPA02001807A (es) 2003-07-14
EP1207898A2 (en) 2002-05-29
ATE289203T1 (de) 2005-03-15
BR0013665A (pt) 2002-05-14
CN1382057A (zh) 2002-11-27
AU780773B2 (en) 2005-04-14

Similar Documents

Publication Publication Date Title
NO20005888L (no) Benzimidazolderivater som mudulatorer av IgE
TNSN00010A1 (fr) DIPHENYLUREE A SUBSTITUTION ω CARBOXYARYLE SERVANT D'INHIBUTEURS DE RAF KINASE.
NO995544L (no) Forbindelser og metoder for inhibering av ekspresjonen av VCAM-1
DE60036968D1 (de) Adamantanderivate zur Behandlung von entzündlichen, immunologischen und kardiovaskulären Erkrankungen
CY1108722T1 (el) Πολυκυκλικες ενωσεις και η χρηση τους ως αναστολεων των ενζυμων parp, vegfr2 και mlk3
DE60139401D1 (de) Erweiterung des bereichs rechnerischer körper von ganzen zahlen
DK0705100T3 (da) Terapeutiske substituerede guanidiner
TR200200673T2 (tr) Rinovirüs enfeksiyonlarında csaıd'lerin kullanılması
TR200101756T2 (tr) Protein kinaz inhibitörleri olarak 4,5-pirazinoksindoller.
CY1105482T1 (el) Χρηση της αζιθρομυκινης στην τοπικη αγωγη οφθαλμικων μολυνσεων
NO991619L (no) Anvendelse av en H+, K+-ATPase-inhibitor i behandlingen av nesepolypper
TR200000907T2 (tr) Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.
PT1207898E (pt) Tratamento da conjuntivite com proteinas histacalinicas
FR2828884B1 (fr) Hydrazinopeptoides et leurs utilisations dans le traitement des cancers
DE69928244D1 (de) Inhibitoren der nf-kb aktivierung
PT1207899E (pt) Tratamento da rinite alergica com certas proteinas de ligacao de aminas vasoactivas
DE60122898D1 (de) Aldosteronantagonist und cyclooxygenase-2 hemmer-kombinationstherapie zur verhinderung oder behandlung von entzündungsverwandten kardiovaskulären krankheiten
DE60017136D1 (de) Behandlung von angiogenese-abhängigen erkrankungen mit dextrinsulphat
ATE331524T1 (de) Verwendung von lps zur behandlung intestinaler entzündungsprozesse
ITMI961070A0 (it) Prevenzione e trattamento delle infezioni virali topiche con perfluoropolietere o loro composizioni.
TNSN00242A1 (en) VALDECOXIB COMPOSITIONS
ES2059209T3 (es) Pirimido-benzotiazinas con accion inhibidora de la lipoxigenasa.